256.13BMarket Cap21.18P/E (TTM)
103.000High100.120Low9.55MVolume101.690Open99.750Pre Close965.15MTurnover0.38%Turnover Ratio723.21P/E (Static)2.53BShares133.73552wk High5.76P/B255.81BFloat Cap94.48052wk Low3.08Dividend TTM2.53BShs Float133.735Historical High3.04%Div YieldTTM2.89%Amplitude18.000Historical Low101.016Avg Price1Lot Size
Merck & Co Stock Forum
So what are the five worst performers on the Dow Jones Industrial Average list of blue chip stocks? Let's take a look.
1. Boeing (down 36.5%)
Boeing $Boeing (BA.US)$ has had a r...
On oct 10/24, open 2 x mrk contracts at 109.29c, strike at 105 and premium of 192 x 2 (35 dte). On nov 5/24, i closed 2 x contracts a...
Merck’s Investigational Zilovertamab Vedotin in Combination With R-CHP Demonstrates Complete Response Rate of 100% at 1.75 mg/kg Dose in Phase 2 Trial of Previously Untreated Patients With Diffuse Large B-Cell Lymphoma
Positive
100% complete response rate achieved at 1.75 mg/kg dose level
High overall response rate across all dosage groups (93.3-100%)
Strong 12-month duration of response at 93.5%
Successfully established recommended Phase 3 dose
Negative
58% of patients exp...
No comment yet